User: Guest

PULMONARY HYPERTENSION

Global Market Trajectory & Analytics

MCP14283

VALIDATED EXECUTIVE ENGAGEMENTS

POOL + OUTREACH

9423
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

1319
Interactions with Platform & by Email

PARTICIPANTS

283
Unique # Participated

VALIDATIONS

127
Responses Validated*
* Login to view program details and full enterprise executive list.

DATE

JULY 2020

TABLES

108

PAGES

184

EDITION

9

PRICE

USD $4950


Amid the COVID-19 crisis, the global market for Pulmonary Hypertension estimated at US$3.5 Billion in the year 2020, is projected to reach a revised size of US$4.3 Billion by 2027, growing at a CAGR of 2.8% over the analysis period 2020-2027. Oral, one of the segments analyzed in the report, is projected to record a 3.1% CAGR and reach US$3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Injectables segment is readjusted to a revised 2.1% CAGR for the next 7-year period.
The Pulmonary Hypertension market in the U.S. is estimated at US$1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$765.4 Million by the year 2027 trailing a CAGR of 2.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.7% and 2.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.
In the global Inhalation segment, USA, Canada, Japan, China and Europe will drive the 2.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$268.9 Million in the year 2020 will reach a projected size of US$322.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$477.9 Million by the year 2027.We bring years of research experience to this 9th edition of our report. The 184-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Abbott Laboratories; Actelion Pharmaceuticals Ltd.; AstraZeneca PLC; Bayer Healthcare AG; Boehringer Ingelheim International GmbH; F. Hoffmann-La Roche AG; GlaxoSmithKline PLC; Merck & Co., Inc.; Novartis AG; Pfizer, Inc.; Teva Pharmaceutical Industries Ltd.; United Therapeutics Corporation; Vectura Group PLC
» Mechanism of Action (Endothelin Receptor Antagonists, Prostacyclin Analogs, Phosphodiesterase Inhibitors, Soluble Guanylate Cyclase Stimulators) » Type (Oral, Injectables, Inhalation)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

INSIDER ACCESS PRIVILEGES

Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.

ACTIVE CLIENT

INACTIVE CLIENT

ACTIVE PANELIST

INACTIVE PANELIST

OPT-INS

FEATURED COMPANIES

Registration is required to access our data stacks.

WORLD BRANDS

Registration is required to access our data stacks.

EXECUTIVES ENGAGED

Registration is required to access our data stacks.

KEY DIFFERENTIATORS

We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.

* A review of 262 off-the-shelf market report publishers worldwide.

WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.

Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.

Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)

A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.

Where relevent and possible we present competitive brands.

Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.

Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.

Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.

We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.

  
05
1. MARKET OVERVIEW
Impact of Covid-19 and a Looming Global Recession
Global Competitor Market Shares
Pulmonary Hypertension Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Pulmonary Hypertension Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
Pulmonary Hypertension Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
Pulmonary Hypertension Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
Endothelin Receptor Antagonists (Mechanism of Action) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025
Endothelin Receptor Antagonists (Mechanism of Action) Market Historic Review by Region/Country in US$ Million: 2009 to 2017
Endothelin Receptor Antagonists (Mechanism of Action) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
Prostacyclin Analogs (Mechanism of Action) World Market by Region/Country in US$ Million: 2018 to 2025
Prostacyclin Analogs (Mechanism of Action) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
Prostacyclin Analogs (Mechanism of Action) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
Phosphodiesterase Inhibitors (Mechanism of Action) World Market Estimates and Forecasts in US$ Million by Region/Country: 2018 to 2025
Phosphodiesterase Inhibitors (Mechanism of Action) Market Worldwide Historic Review by Region/Country in US$ Million: 2009 to 2017
Phosphodiesterase Inhibitors (Mechanism of Action) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025
Soluble Guanylate Cyclase Stimulators (Mechanism of Action) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2018 to 2025
Soluble Guanylate Cyclase Stimulators (Mechanism of Action) Global Historic Demand in US$ Million by Region/Country: 2009 to 2017
Soluble Guanylate Cyclase Stimulators (Mechanism of Action) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
Oral (Type) World Market by Region/Country in US$ Million: 2018 to 2025
Oral (Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
Oral (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
Injectables (Type) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
Injectables (Type) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
Injectables (Type) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
Inhalation (Type) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025
Inhalation (Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017
Inhalation (Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Pulmonary Hypertension Market Share (in %) by Company: 2019 & 2025
United States Pulmonary Hypertension Market Estimates and Projections in US$ Million by Mechanism of Action: 2018 to 2025
Pulmonary Hypertension Market in the United States by Mechanism of Action: A Historic Review in US$ Million for 2009-2017
United States Pulmonary Hypertension Market Share Breakdown by Mechanism of Action: 2009 VS 2019 VS 2025
United States Pulmonary Hypertension Market Estimates and Projections in US$ Million by Type: 2018 to 2025
Pulmonary Hypertension Market in the United States by Type: A Historic Review in US$ Million for 2009-2017
United States Pulmonary Hypertension Market Share Breakdown by Type: 2009 VS 2019 VS 2025
CANADA
Canadian Pulmonary Hypertension Market Estimates and Forecasts in US$ Million by Mechanism of Action: 2018 to 2025
Canadian Pulmonary Hypertension Historic Market Review by Mechanism of Action in US$ Million: 2009-2017
Pulmonary Hypertension Market in Canada: Percentage Share Breakdown of Sales by Mechanism of Action for 2009, 2019, and 2025
Canadian Pulmonary Hypertension Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025
Canadian Pulmonary Hypertension Historic Market Review by Type in US$ Million: 2009-2017
Pulmonary Hypertension Market in Canada: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
JAPAN
Japanese Market for Pulmonary Hypertension: Annual Sales Estimates and Projections in US$ Million by Mechanism of Action for the Period 2018-2025
Pulmonary Hypertension Market in Japan: Historic Sales Analysis in US$ Million by Mechanism of Action for the Period 2009-2017
Japanese Pulmonary Hypertension Market Share Analysis by Mechanism of Action: 2009 VS 2019 VS 2025
Japanese Market for Pulmonary Hypertension: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025
Pulmonary Hypertension Market in Japan: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017
Japanese Pulmonary Hypertension Market Share Analysis by Type: 2009 VS 2019 VS 2025
CHINA
Chinese Pulmonary Hypertension Market Growth Prospects in US$ Million by Mechanism of Action for the Period 2018-2025
Pulmonary Hypertension Historic Market Analysis in China in US$ Million by Mechanism of Action: 2009-2017
Chinese Pulmonary Hypertension Market by Mechanism of Action: Percentage Breakdown of Sales for 2009, 2019, and 2025
Chinese Pulmonary Hypertension Market Growth Prospects in US$ Million by Type for the Period 2018-2025
Pulmonary Hypertension Historic Market Analysis in China in US$ Million by Type: 2009-2017
Chinese Pulmonary Hypertension Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
EUROPE
Market Facts & Figures
European Pulmonary Hypertension Market: Competitor Market Share Scenario (in %) for 2019 & 2025
European Pulmonary Hypertension Market Demand Scenario in US$ Million by Region/Country: 2018-2025
Pulmonary Hypertension Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
European Pulmonary Hypertension Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
European Pulmonary Hypertension Market Estimates and Forecasts in US$ Million by Mechanism of Action: 2018-2025
Pulmonary Hypertension Market in Europe in US$ Million by Mechanism of Action: A Historic Review for the Period 2009-2017
European Pulmonary Hypertension Market Share Breakdown by Mechanism of Action: 2009 VS 2019 VS 2025
European Pulmonary Hypertension Market Estimates and Forecasts in US$ Million by Type: 2018-2025
Pulmonary Hypertension Market in Europe in US$ Million by Type: A Historic Review for the Period 2009-2017
European Pulmonary Hypertension Market Share Breakdown by Type: 2009 VS 2019 VS 2025
FRANCE
Pulmonary Hypertension Market in France by Mechanism of Action: Estimates and Projections in US$ Million for the Period 2018-2025
French Pulmonary Hypertension Historic Market Scenario in US$ Million by Mechanism of Action: 2009-2017
French Pulmonary Hypertension Market Share Analysis by Mechanism of Action: 2009 VS 2019 VS 2025
Pulmonary Hypertension Market in France by Type: Estimates and Projections in US$ Million for the Period 2018-2025
French Pulmonary Hypertension Historic Market Scenario in US$ Million by Type: 2009-2017
French Pulmonary Hypertension Market Share Analysis by Type: 2009 VS 2019 VS 2025
GERMANY
Pulmonary Hypertension Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Mechanism of Action for the Period 2018-2025
German Pulmonary Hypertension Historic Market Analysis in US$ Million by Mechanism of Action: 2009-2017
German Pulmonary Hypertension Market Share Breakdown by Mechanism of Action: 2009 VS 2019 VS 2025
Pulmonary Hypertension Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
German Pulmonary Hypertension Historic Market Analysis in US$ Million by Type: 2009-2017
German Pulmonary Hypertension Market Share Breakdown by Type: 2009 VS 2019 VS 2025
ITALY
Italian Pulmonary Hypertension Market Growth Prospects in US$ Million by Mechanism of Action for the Period 2018-2025
Pulmonary Hypertension Historic Market Analysis in Italy in US$ Million by Mechanism of Action: 2009-2017
Italian Pulmonary Hypertension Market by Mechanism of Action: Percentage Breakdown of Sales for 2009, 2019, and 2025
Italian Pulmonary Hypertension Market Growth Prospects in US$ Million by Type for the Period 2018-2025
Pulmonary Hypertension Historic Market Analysis in Italy in US$ Million by Type: 2009-2017
Italian Pulmonary Hypertension Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED KINGDOM
United Kingdom Market for Pulmonary Hypertension: Annual Sales Estimates and Projections in US$ Million by Mechanism of Action for the Period 2018-2025
Pulmonary Hypertension Market in the United Kingdom: Historic Sales Analysis in US$ Million by Mechanism of Action for the Period 2009-2017
United Kingdom Pulmonary Hypertension Market Share Analysis by Mechanism of Action: 2009 VS 2019 VS 2025
United Kingdom Market for Pulmonary Hypertension: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025
Pulmonary Hypertension Market in the United Kingdom: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017
United Kingdom Pulmonary Hypertension Market Share Analysis by Type: 2009 VS 2019 VS 2025
REST OF EUROPE
Rest of Europe Pulmonary Hypertension Market Estimates and Forecasts in US$ Million by Mechanism of Action: 2018-2025
Pulmonary Hypertension Market in Rest of Europe in US$ Million by Mechanism of Action: A Historic Review for the Period 2009-2017
Rest of Europe Pulmonary Hypertension Market Share Breakdown by Mechanism of Action: 2009 VS 2019 VS 2025
Rest of Europe Pulmonary Hypertension Market Estimates and Forecasts in US$ Million by Type: 2018-2025
Pulmonary Hypertension Market in Rest of Europe in US$ Million by Type: A Historic Review for the Period 2009-2017
Rest of Europe Pulmonary Hypertension Market Share Breakdown by Type: 2009 VS 2019 VS 2025
ASIA-PACIFIC
Pulmonary Hypertension Market in Asia-Pacific by Mechanism of Action: Estimates and Projections in US$ Million for the Period 2018-2025
Asia-Pacific Pulmonary Hypertension Historic Market Scenario in US$ Million by Mechanism of Action: 2009-2017
Asia-Pacific Pulmonary Hypertension Market Share Analysis by Mechanism of Action: 2009 VS 2019 VS 2025
Pulmonary Hypertension Market in Asia-Pacific by Type: Estimates and Projections in US$ Million for the Period 2018-2025
Asia-Pacific Pulmonary Hypertension Historic Market Scenario in US$ Million by Type: 2009-2017
Asia-Pacific Pulmonary Hypertension Market Share Analysis by Type: 2009 VS 2019 VS 2025
REST OF WORLD
Rest of World Pulmonary Hypertension Market Estimates and Forecasts in US$ Million by Mechanism of Action: 2018 to 2025
Rest of World Pulmonary Hypertension Historic Market Review by Mechanism of Action in US$ Million: 2009-2017
Pulmonary Hypertension Market in Rest of World: Percentage Share Breakdown of Sales by Mechanism of Action for 2009, 2019, and 2025
Rest of World Pulmonary Hypertension Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025
Rest of World Pulmonary Hypertension Historic Market Review by Type in US$ Million: 2009-2017
Pulmonary Hypertension Market in Rest of World: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
Total Companies Profiled : 8

Click here to request a full table of contents and more details on this project.

INSIDER ACCESS TO

 METHODOLOGY  QUESTIONNAIRE  INFLUENCER NETWORK

Registration is required to access our data stacks.

RESEARCH PANEL

Panelists are carefully chosen based on their domain expertise and market influence.

Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.

Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.

  • Complimentary previews of full stack research data for participated
  • Insider access to research programs including engagements and stats from other panelists
  • Unlimited research credits of $1000 per participated project
  • Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
  • Interact with other panelists via our MarketGlassTM Data Exchange Platform*
  • BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*

* Complete details will be shared with panelists upon formal acceptance.

 GLOBAL EXPERT PANEL

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com